ProGnosis Biotech S.A.

ProGnosis Biotech, headquartered in Greece, is a global diagnostics provider with 11 subsidiaries and distributors in over 90 countries. The company offers a wide range of ELISA kits and lateral flow tests for the detection of mycotoxins, food allergens, antibiotic residues, GMOs, milk adulteration and histamine. It also provides hygiene monitoring solutions, including ATP detection and clinical diagnostics. ProGnosis Biotech also designs and produces proprietary antibodies, hardware and software, including an Android mobile app for instant report sharing.Committed to sustainable practices, it emphasizes green extraction methods and digital traceability, empowering safer food chains and protecting consumer health worldwide.